Dissolution/drug release tests for parenteral products

• In: S1 - Dissolution testing: A pivotal tool for development and quality of drugs on Monday, 3 September 2007, 9:00-12:00
• At: Beijing (China) (2007)
• Type: Presentation
• By: STICKELMEYER, Mary (Eli Lilly and Company, Indianapolis, IN, United States of America)
• Abstract:

  Parenteral controlled release dosage forms are becoming more prevalent due to the fact that they can increase patient compliance, are capable of constant drug levels in vivo and thus offer improved therapeutic response for patients, and reduce the frequency for administration of the medication. Controlled release parenteral delivery systems

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login